Connor, Clark & Lunn Investment Management Ltd. Astrazeneca PLC Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $21.8 Billion
  • Q1 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 9,961 shares of AZN stock, worth $776,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,961
Previous 10,190 2.25%
Holding current value
$776,858
Previous $686,000 1.75%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$61.03 - $69.57 $13,975 - $15,931
-229 Reduced 2.25%
9,961 $674,000
Q4 2023

Feb 09, 2024
SELL
$61.89 - $69.28 $76,124 - $85,214
-1,230 Reduced 10.77%
10,190 $686,000
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $26,264 - $29,038
-405 Reduced 3.42%
11,420 $773,000
Q2 2023

Aug 10, 2023
BUY
$69.91 - $75.81 $39,499 - $42,832
565 Added 5.02%
11,825 $846,000
Q1 2023

May 09, 2023
SELL
$63.15 - $71.6 $4.45 Million - $5.05 Million
-70,498 Reduced 86.23%
11,260 $781,000
Q4 2022

Feb 10, 2023
SELL
$54.21 - $70.44 $8.88 Million - $11.5 Million
-163,718 Reduced 66.69%
81,758 $5.54 Million
Q3 2022

Nov 10, 2022
SELL
$53.02 - $135.75 $32.1 Million - $82.2 Million
-605,306 Reduced 71.15%
245,476 $13.5 Million
Q2 2022

Aug 05, 2022
BUY
$59.26 - $71.14 $50 Million - $60.1 Million
844,177 Added 12780.88%
850,782 $56.2 Million
Q1 2022

May 12, 2022
SELL
$55.72 - $67.12 $1.28 Million - $1.54 Million
-22,925 Reduced 77.63%
6,605 $438,000
Q4 2021

Feb 10, 2022
BUY
$54.02 - $63.83 $1.6 Million - $1.88 Million
29,530 New
29,530 $1.72 Million
Q3 2020

Nov 12, 2020
SELL
$53.07 - $61.1 $5.86 Million - $6.74 Million
-110,350 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$43.1 - $55.31 $4.76 Million - $6.1 Million
110,350 New
110,350 $5.84 Million
Q3 2019

Nov 13, 2019
SELL
$40.12 - $45.47 $4.53 Million - $5.13 Million
-112,900 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$37.28 - $41.68 $2.84 Million - $3.18 Million
76,200 Added 207.63%
112,900 $4.66 Million
Q1 2019

May 08, 2019
SELL
$35.49 - $43.02 $1.42 Million - $1.72 Million
-40,000 Reduced 52.15%
36,700 $1.48 Million
Q4 2018

Feb 12, 2019
BUY
$36.86 - $41.49 $2.83 Million - $3.18 Million
76,700 New
76,700 $2.91 Million
Q3 2017

Nov 14, 2017
SELL
$28.96 - $34.0 $3.65 Million - $4.29 Million
-126,100 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
126,100
126,100 $4.3 Million

Others Institutions Holding AZN

# of Institutions
1,246
Shares Held
477M
Call Options Held
5.99M
Put Options Held
5.24M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email